SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 11,551.32 |
| Enterprise Value ($M) | 10,501.13 |
| Book Value ($M) | 3,417.63 |
| Book Value / Share | 27.42 |
| Price / Book | 3.38 |
| NCAV ($M) | 2,071.75 |
| NCAV / Share | 16.62 |
| Price / NCAV | 5.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.15 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.88 |
| Current Ratio | 17.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,213.86 |
| Assets | 3,559.75 |
| Liabilities | 142.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 9.80 | 56.44 | |
| 13G/A | Ra Capital Management, L.p. | 9.99 | 30.61 | |
| 13G/A | Fmr Llc | 12.84 | 10.79 | |
| 13G/A | Vanguard Group Inc | 8.88 | 27.80 | |
| 13G/A | BlackRock, Inc. | 9.00 | 67.97 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 738,075 | 4,407,126 | 16.75 | |
| 587,383 | 2,879,804 | 20.40 | |
| 193,096 | 1,533,973 | 12.59 | |
| 214,610 | 1,345,651 | 15.95 | |
| 98,770 | 754,373 | 13.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PASG – Passage Bio, Inc. | PBYI – Puma Biotechnology, Inc. |
| PCRX – Pacira BioSciences, Inc. | PEPG – PepGen Inc. |
| PGEN – Precigen, Inc. |
Financial data and stock pages provided by
Fintel.io